Mitchell v. Carnrick Laboratories, Inc.

Court: Appellate Division of the Supreme Court of the State of New York
Date filed: 1997-03-25
Citations: 237 A.D.2d 194, 655 N.Y.S.2d 468
Copy Citations
Click to Find Citing Cases
Lead Opinion

—Order, Supreme Court, New York County (Ira Gammerman, J.), entered November 21, 1995, which, upon granting plaintiff’s motion for reargument, adhered to a prior order, same court and Justice, entered July 27, 1995, to the extent that it granted defendants-respondents’ motion for summary judgment dismissing the complaint, unanimously affirmed, without costs.

Plaintiffs cause of action for injuries allegedly suffered as a result of his exposure to diethylstilbestrol (DES) accrued in Georgia, where his mother had purchased and ingested the drug, and not where the injury first became manifest (Godfrey v Eli Lilly & Co., 223 AD2d 427, lv denied 88 NY2d 801). Because Georgia does not recognize non-identification theories of liability in cases such as this (see, Blackston v Shook & Fletcher Insulation Co., 764 F2d 1480, 1483), the complaint must be dismissed (Godfrey v Eli Lilly & Co., supra).

We have considered plaintiff’s other contentions and find them to be without merit. Concur—Murphy, P. J., Sullivan, Rubin and Andrias, JJ.